Global Medical Director - Respiratory Biologics

The Global Medical Director for Respiratory Biologics at GlaxoSmithKline (GSK) will be responsible for leading the clinical development strategy for GSK’s respiratory biologics portfolio. As the Global Medical Director, you will be working in a highly collaborative environment to ensure that the team is providing the best possible patient outcomes. We are looking for an experienced and innovative individual who is passionate about discovering treatments and cures for respiratory diseases.The ideal candidate will have a medical degree, with several years of experience in the biopharmaceutical industry, preferably in the respiratory field. They will have a clear understanding of the drug development process and the regulatory environment. In addition, they should have excellent communication skills, be knowledgeable in the scientific and clinical aspects of biologics, and be able to effectively interact with key stakeholders. The successful candidate will have a strong commitment to patient-centricity and an unwavering focus on developing the best treatments for respiratory diseases.

Responsibilities:

1. Lead the clinical development strategy for GSK’s respiratory biologics portfolio.
2. Ensure that the team is providing the best possible patient outcomes.
3. Develop and maintain strong relationships with key stakeholders.
4. Maintain a clear understanding of the drug development process and the regulatory environment.
5. Remain knowledgeable in the scientific and clinical aspects of biologics.
6. Effectively communicate with internal and external partners.
7. Develop treatments and cures for respiratory diseases.
8. Adhere to patient-centricity and an unwavering focus on developing the best treatments for respiratory diseases.

According to JobzMall, the average salary range for a Global Medical Director - Respiratory Biologics in Collegeville, PA 19426, USA is $200,000 - $300,000 per year. This range includes base salary, bonus, and other compensation such as stock options and performance-based incentives.

GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infective, dermatology, gynecology, diabetes, cardiovascular disease and respiratory diseases. The company also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others.